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Abstract
Background: There is controversy about chronic health consequences of tick-borne infections, especially Lyme
borreliosis. This study aims to assess whether general function, physical fitness and subjective health complaints are
associated with tick bites or antibodies to Borrelia burgdorferi sensu lato in blood donors.
Methods: Sera from 1,213 blood donors at four different blood banks in Sogn and Fjordane county in western
Norway were obtained during January to June 2010, and analysed for specific IgG and IgM antibodies. A
questionnaire including questions on tick bites, subjective health complaints, general function and physical fitness
was completed.
Results: Tick bites had been experienced by 65.7 % of the study population. 78 (6.4 %) were positive for IgG (9.7 %
in men, 2.4 % in women), and 69 (5.7 %) for IgM (6.1 % in men, 5.1 % in women), verified by immunoblot. No
association between number of experienced tick bites or seropositivity for Borrelia antibodies and subjective health
complaints, reduced general function or reduced physical fitness was found.
Conclusion: The results do not support any association between tick bites or Borrelia antibodies and subjective
health complaints in blood donors in an endemic area for Lyme borreliosis.
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Background
There is much controversy about chronic health conse-
quences of treated and untreated Lyme borreliosis (LB)
[1–4]. Symptoms from many organ systems are ascribed
to “chronic LB”, including fatigue, stiff neck, migrating
arthralgias, myalgia, chest pain, palpitations, abdominal
pain, nausea, back pain, headaches, etc. [3]. In addition,
other agents transmitted by ticks, e.g., Rickettsia spp.,
are increasingly claimed to cause health problems [5].
In follow-up studies of patients with Lyme neurobor-
reliosis (LNB), several symptoms have been found to
persist in some of the patients compared to controls,
including malaise, fatigue, memory problems, concentra-
tion difficulties and paresthesias [6, 7].
Population based follow-up studies of patients treated
for LB in general have given discrepant results regarding
long-term consequences. Some American studies have
reported that LB patients experience long-lasting symp-
toms [8, 9], while other investigations found that symp-
toms at follow-up did not exceed that of a control
population [10–14].
European studies have also shown that patients having
suffered from early LB report a number of symptoms;
however, these did not exceed the corresponding symp-
toms in matched controls [15, 16].
In a recent Swedish study, patients bitten by Borrelia-
infected ticks were compared to patients bitten by non-
infected ticks [17]. The frequency of subjects reporting
symptoms was higher in the group bitten by Borrelia-
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infected ticks compared to subjects bitten by uninfected
ticks. There were, however, no differences between
subjects bitten by a Borrelia-positive tick and subjects
bitten by a Borrelia-negative tick when comparing the
frequency of reported experience of several symptoms,
such as fatigue, myalgia/arthralgia, headache, and
neck pain.
It thus seems that long-lasting symptoms after LNB
are frequent in adults; however, in properly controlled
studies, lasting symptoms are rarely seen after early dis-
ease manifestations such as erythema migrans or after
bites with Borrelia-infected ticks.
A majority of blood donors in Sogn and Fjordane
county have experienced tick bites [18], and the sero-
prevalence of antibodies to B. burgdorferi s.l. is substan-
tial [19]. The aim of this study was to assess the
association, if any, of general function, physical fitness
and subjective health complaints with reported tick bites




During the period January 13th to June 15th 2010, blood
donors at the four blood banks in Sogn and Fjordane were
asked to participate in the Tick-borne Infection Study in
Sogn and Fjordane. A total of 1,213 blood donors partici-
pated, a response rate of 76 %. The mean age was
45.8 years, ranging from 19 to 69. Men constituted 55.2 %.
Further characteristics of the participants are presented
elsewhere [18]. Informed consent was obtained from each
participant, and the study was approved by the Regional
Committee for Medical Research Ethics. This investiga-
tion included a questionnaire in addition to testing serum
samples for antibodies to B. burgdorferi s.l., tick-borne en-
cephalitis virus and Anaplasma phagocytophilum. The re-
ported occurrence of tick bites and the results of the
antibody tests in this study population have been pub-
lished elsewhere [18–20].
Questionnaire
The questionnaire included questions about demograph-
ics such as gender, age, marital status, education, house-
hold income and occupation. Questions on pet animals,
farm animals, hours spent outdoors during summertime,
hunting, orienteering, smoking, and symptoms and
treatment after tick bites were also included.
The questionnaire included two questions on tick
bites; tick bites ever experienced, and tick bites expe-
rienced during the last 12 months. The responses for
both questions were given in the categories “none”,
“one”, “2-5”, “6-20” and “more than 20”. The number of
tick bites ever experienced was used in the present
study.
Another section of the questionnaire included the
Subjective Health Complaints (SHC) Inventory, a set of
questions designed to measure common and prevalent
health complaints in the general population [21–23].
The respondents reported to what extent they had been
affected by 29 different health disturbances during the
last month. The response options were “Not at all”
(score 0), “A little” (score 1), “Some” (score 2), and “Ser-
ious” (score 3). In addition, the respondents were asked
to record the duration of these symptoms (1–30 days).
The question related to general function was “How do
you assess your ability to perform ordinary activity, your
general function, is today?” The response options were
“Good, as it usually is” (score 0), “Hardly reduced at all”
(score 1), “Not much reduced” (score 2), “Moderately re-
duced” (score 3) and “Much reduced” (score 4), adapted
from [24].
Physical fitness was assessed by the question “«Dur-
ing the past 2 weeks: What was the hardest physical
activity you could do for at least 2 min?», with the
response alternatives «Very heavy (ex. run, at fast
pace)» (score 0), « Heavy (ex. jog, at slow pace)»
(score 1), « Moderate (ex. walk, at a fast pace)»
(score 2), «Light (ex. walk, at a medium pace)» (score 3),
and «Very light (ex. walk, at a slow pace or not able to
walk)» (score 4). This question was taken from the
COOP/WONCA charts [25].
The questionnaires were answered anonymously, and
most were completed during the time spent at the blood
bank for routine donation.
Laboratory methods
For testing of antibodies to B. burgdorferi s.l., all sera
were tested in Enzygnost Lyme link VlsE/IgG and
Enzygnost Borreliosis IgM (DADE Behring, Marburg,
Germany) and in Immunetics C6 Lyme ELISA kit
(Immunetics, Cambridge, MA, USA). Sera showing
positive or grey-zone reactivities in any of these tests
were further tested in Borrelia-EUROLine-RN-AT IgG
and Borrelia-EUROLine-RN-AT IgM (Euroimmun AG,
Lübeck, Germany) immunoblots. Further details are pre-
sented elsewhere [19]. The results of the immunoblots are
used in the present study, and are here-after referred to as
IgG and IgM.
Risk factors
The three risk factors included in the present analyses
were the number of self-reported tick bites ever experi-
enced, positive IgG, and positive IgM for B. burgdorferi
sensu lato. With the exeption of the questions on gen-
eral function and physical fitness (Table 1), the numbers
of tick bites were dichotomised into less than two versus
two or more in the analyses.
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Outcome
The outcome variables in this study were the responses
to questions on subjective health complaints (SHC), gen-
eral function, and physical fitness.
For general function and physical fitness, the response
was categorized in the categories 0–3, i.e., categories 3
and 4 were merged, because of few respondents in cat-
egory 4.
For the SHC-questions, we calculated the total num-
ber of complaints reported by each participant. In
addition, a total SHC score was computed as the sum of
the severity scores of all 29 items in the questionnaire,
the computation of this score was allowed if 18 or more
of the questions were answered.
The proportion of subjects reporting any complaint
within five subscales are reported as well; these include
“musculoskeletal” complaints (headache, neck pain,
shoulder pain, pain in arms, pain in upper back, low
back pain, leg pain, and pain in the feet during exercise),
“pseudoneurological” complaints (extra heartbeats, heat
flushes, sleep problems, tiredness, dizziness, anxiety and
sadness/depression), “gastrointestinal” complaints (heart-
burn, stomach discomfort, ulcer/non-ulcer dyspepsia,
stomach pain, bloating, diarrhoea and constipation),
“allergic” complaints (asthma, breathing difficulties, ec-
zema, allergies and chest pain) and “flu” (cold/flu and
cough). These subscales are based on factor analysis and
the factors have shown good reliability in previous stud-
ies [21]. The computation of these proportions allowed
for a certain number of missing values, which were ig-
nored if constituting less than half of the questions
within the subscale.
For the statistical evaluation of each individual SHC
we chose to dichotomize all responses into “no com-
plaint” versus any degree of complaint, as very few
scored the two most serious responses 2 and 3.
Statistical analysis
We used IBM SPSS Statistics version 21 (SPSS Inc.,
Chicago, Illinois) for statistical analyses except for
Table 3, where Stata/SE version 13.1 for Windows
(StataCorp LP, College Station, Texas) was used.
Immunoblot results for IgG and IgM were categorized
as positive or negative, with grey-zone results included
as negatives.
For the questions on general function and physical
fitness, the association between the score and number of
self-reported tick bites was analysed by using propor-
tional odds models, i.e., logistic regression models with
more than two ordinal categorical outcomes, with and
without adjustment for gender, age group and location
of blood bank [26].
Table 1 Overall function and physical fitness in relation to tick bites and Borrelia antibodies
Risk factor Reduced overall function Reduced physical fitness
Odds ratio2 (95 % CI) Adjusted odds ratio3 (95 % CI) Odds ratio2 (95 % CI) Adjusted odds ratio3 (95 % CI)
Total tick bites ever experienced
n1 1167 1145 1179 1157
None (%) 34.1 1 1 1 1
1 (%) 18.1 1.9 (1.0 - 3.5) 1.7 (0.9 - 3.2) 1.2 (0.9 - 1.6) 1.1 (0.8 - 1.5)
2-5 (%) 23.7 0.7 (0.4 - 1.5) 0.7 (0.4 - 1.6) 0.8 (0.6 - 1.0) 0.7 (0.5 - 0.9)
6-20 (%) 15 1. 9 (1.0 - 3.5) 1.8 (0.9 - 3.5) 0.6 (0.5 - 0.9) 0.5 (0.4 - 0.7)
>20 (%) 9.2 2.1 (1.0 - 4.4) 2.0 (0.9 - 4.2) 0.9 (0.6 - 1.3) 0.7 (0.4 - 1.0)
p trend 0.086 0.117 0.012 <0.001
IgG
n1 1179 1157 1191 1169
negative (%) 93.8 1 1 1 1
positive (%) 6.2 1.6 (0.8 - 3.5) 1.7 (0.8 - 3.7) 1.1 (0.7 - 1.7) 1.1 (0.7 - 1.7)
p difference 0.216 0.204 0.725 0.688
IgM
n1 1179 1157 1191 1169
negative (%) 94.3 1 1 1 1
positive (%) 5.7 1.5 (0.7 - 3.5) 1.5 (0.7 -3.4) 1.1 (0.7 - 1.7) 0.9 (0.6 - 1.5)
p difference 0.296 0.340 0.760 0.726
1Numbers do not add to 1,213 due to missing data
2Odds ratio was estimated using proportional odds ratio models (logistic regression model with more than two categorical outcomes)
3Adjusted for gender, age group and blood bank
Hjetland et al. BMC Public Health    Page 3 of 8
For SHC, both individually for each complaint as
well as for the five sub-scales, the associations be-
tween the risk factors and outcome variables were
analysed by binary logistic regression, with and with-
out adjustment for gender, age group and location of
blood bank.
Differences in the total number of complaints and the
total SHC score between groups with and without the
risk factors were estimated by using linear regression
model with robust variance estimation. All p values were
two-sided and values below 0.05 were considered statis-
tical significant.
Results
Among participants, 65.7 % had experienced tick bites dur-
ing their life time. One tick bite was reported by 18.0 %,
2–5 bites by 23.8 %, 6–20 by 14.7 %, and more than 20
bites by 9.2 %. The estimated mean number of tick bites
was 5.7, as published elsewhere [18].
Borrelia IgG antibodies verified by immunoblot were
present in 6.4 % (9.7 % in men and 2,4 % in women),
whereas Borrelia IgM antibodies were demonstrated in
5.7 % (6.1 % in men and 5.1 % in women) [19].
Overall, 5.0 % reported to have received antibiotics be-
cause of tick bite or consequences thereof. Among IgG
and/or IgM blot positives, antibiotics had been received
by 11.9 %.
The results for the relationship between the risk factors
tick bites ever experienced, Borrelia IgG and Borrelia IgM,
and the outcomes general function and physical fitness
are presented in Table 1. The proportion reporting re-
duced general function did not differ significantly between
subjects with and without the risk factors. The number of
tick bites was positively associated with good physical fit-
ness (adjusted p for trend < 0.001).
The relationship between the proportion reporting any
complaint within the five subscales of subjective health
complaints and the risk factors are presented in Table 2,
and results for each of the individual 29 complaints are
presented in the Additional file 1.
There were no significant associations between the
proportion reporting “musculoskeletal pain” or the indi-
vidual related complaints with any of the risk factors.
For the group of “pseudoneurological” complaints, there
were fewer complaints in the subjects with Borrelia
IgG than in those without these antibodies (adjusted
Table 2 Odds ratio for reporting any degree of subjective health complaint (SHC), grouped in five subscales
Complaint/Risk factor (RF) n1 Proportion with complaint (%) Odds ratio2 (OR) for complaint when risk factor present
RF absent RF present Unadjusted p3 Adjusted4 p3
Musculoskeletal pain
Tick bites >1 1139 66.6 68.1 1.1 (0.8 - 1.4) 0.583 1.1 (0.8 - 1.4) 0.578
IgG + 1151 67.1 69.0 1.1 (0.6 - 1.8) 0.743 1.3 (0.7 - 2.2) 0.374
IgM + 1151 66.9 72.6 1.3 (0.7 - 2.3) 0.359 1.5 (0.8 - 2.7) 0.172
Pseudoneurology
Tick bites >1 1136 40.8 39.2 0.9 (0.7 - 1.2) 0.570 0.9 (0.7 - 1.1) 0.264
IgG + 1148 41.1 23.9 0.5 (0.3 - 0.8) 0.005 0.5 (0.3 - 0.8) 0.010
IgM + 1148 40.2 37.1 0.9 (0.5 - 1.5) 0.624 0.8 (0.5 - 1.5) 0.522
Gastrointestinal complaints
Tick bites >1 1136 41.5 42.1 1.0 (0.8 - 1.3) 0.829 1.0 (0.8 - 1.3) 0.991
IgG + 1148 42.0 38.0 0.8 (0.5 - 1.4) 0.515 0.9 (0.5 - 1.4) 0.557
IgM + 1148 41.4 46.8 1.2 (0.7 - 2.1) 0.408 1.1 (0.7 - 1.9) 0.632
Allergy
Tick bites >1 1136 20.2 19.8 1.0 (0.7 - 1.3) 0.870 0.9 (0.7 - 1.2) 0.534
IgG + 1148 20.2 16.9 0.8 (0.4 - 1.5) 0.497 0.8 (0.4 - 1.5) 0.415
IgM + 1148 19.7 25.8 1.4 (0.8 - 2.6) 0.245 1.4 (0.7 - 2.5) 0.324
Flu
Tick bites >1 1161 29.3 31.4 1.1 (0.9 - 1.4) 0.434 1.2 (0.9 - 1.5) 0.264
IgG + 1174 29.7 36.5 1.4 (0.8 - 2.2) 0.222 1.3 (0.8 - 2.2) 0.273
IgM + 1174 29.5 42.2 1.7 (1.0 - 2.9) 0.033 1.3 (0.8 - 2.2) 0.273
1n does not reach 1213 because of missing data
2Odds ratio for subjects without the risk factor is 1
3Binary logistic regression
4Adjusted for gender, age group and blood bank location
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p = 0.010). None of the individual complaints in this
group of questions were significantly associated with
any of the risk factors. However, for all questions
there were fewer in the IgG positive group reporting
symptoms than among IgG negatives (Additional file 1).
In the subscale “gastrointestinal” complaints, some
more subjects with more than one tick bite reported
ulcer- and non-ulcer dyspepsia (adjusted p = 0.079), and
there was a trend towards more IgM positives reporting
constipation (Additional file 1; adjusted p = 0.081).
There were no significant associations between
the number of subjects reporting complaints within the
“allergy” subscale or the individual related complaints
with any of the risk factors.
The “flu”-related questions all showed a higher per-
centage of IgM positives reporting symptoms, however,
this associations were weakened when adjusted for gen-
der, age group and blood bank location.
We found no significant associations between the total
number of subjective health complaints or the total SHC
score and any of the risk factors (Table 3) when adjusted
for gender, age, and location of blood bank.
The additional questions on duration of the different
symptoms were answered by only 60 % (38-73 %) of the
subjects reporting any degree of the complaints. There-
fore, these data were not considered satisfactory for statis-
tical evaluation and are not shown.
Discussion
The main finding in this study was the lack of association
between the risk factors tick bites and Borrelia antibodies
with the outcomes subjective health complaints, reduced
Table 3 Number of subjective health complaints and total SHC score relative to tick bites and Borrelia antibodies
No. subjects1 Median (IQR)2 Mean (SEM)3 Adjusted mean (SEM)3,4
Number of complaints
Tick-bites
≤1 624 3.0 (1.0-5.0) 3.59 (0.14) 3.62 (0.13)
>1 570 3.0 (1.0-5.0) 3.64 (0.13) 3.60 (0.14)
p difference 0.785 0.903
IgG
- 1135 3.0 (1.0-5.0) 3.62 (0.10) 3.63 (0.10)
+ 78 2.0 (1.0-4.0) 3.29 (0.50) 3.42 (0.51)
p difference 0.527 0.603
IgM
- 1144 3.0 (1.0-5.0) 3.58 (0.10) 3.60 (0.10)
+ 69 3.0 (1.0-5.0) 3.94 (0.51) 3.87 (0.51)
p difference 0.480 0.600
Total SCH score5
Tick-bites
≤1 595 3.0 (1.0-6.0) 4.71 (0.24) 4.76 (0.25)
>1 541 3.1 (1.0-6.0) 4.58 (0.20) 4.51 (0.20)
p difference 0.672 0.440
IgG
- 1077 3.0 (1.0, 6.0) 4.62 (0.14) 4.60 (0.14)
+ 71 3.0 (1.0, 5.0) 5.22 (1.31) 5.36 (1.26)
p difference 0.644 0.550
IgM
- 1086 3.0 (1.0-6.0) 4.57 (0.14) 4.57 (0.14)
+ 62 3.1 (2.0-7.0) 6.06 (1.41) 5.94 (1.35)
p difference 0.295 0.313
1The number of subjects does not reach 1213 because of missing data
2Interquartile range (IQR)
3Standard error of the mean (SEM) predicted by linear regression with robust variance estimation
4Adjusted for gender, age and blood bank location
5SCH: Subjective health complaints. Total SHC score: See text
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general function and reduced physical fitness. On the
contrary, we found a positive association between tick
bites and good physical fitness, and between presence of
Borrelia IgG and low occurrence of “pseudoneurological”
complaints. For most complaints, however, we found no
association.
The risk factor “number of tick bites” was included in
this study to explore the possibility that seronegative LB
or other tick-borne infectious agents not tested for, e.g.
Anaplasma phagocytophilum, Rickettsia spp., etc., could
give rise to chronic health problems of some magnitude.
IgG and IgM antibodies to B. burgdorferi s.l. verified
by blot were chosen as risk factors in this study in order
to avoid including false positive ELISA results. However,
biologically false positive IgM blot results still are a
problem, and American guidelines thus argue against
using IgM blot in the second-tier testing when disease
duration is longer than one month [27]. A proportion of
the IgM blot positive specimens in this study are prob-
ably biologically false positive, as discussed elsewhere
[19]. Also, many will lose their antibodies after a while,
whether treated or not. However, antibodies against
B. burgdorferi s.l., especially IgG, should be an indicator
of former or present infection with this organism.
In several studies of symptoms after LB, the Medical
Outcomes Study 36-Item Short-Form Health Survey
(SF-36) has been used [6, 8–10]. In addition, several
questionnaires for assessing somatic symptoms in the
general population exist [28]. The unique contribution
of the current study was to include the SHC question-
naire, which was designed to measure common and
prevalent health complaints in the general population,
and has been used in several studies of the general
population as well as different patients groups [29–32].
Compared to other surveys using the SHC Inventory
in the general population, summarised by Eriksen et al.
in 1999 [21], and for a working population more recently
by Ihlebæk and co-workers [29], the proportion of sub-
jects with any complaint were lower in our material for
most complaints, reflecting the overall healthy status of
the blood donors (Additional file 1).
Comparing our results to those of other studies is not
straight forward, of two main reasons. Firstly, the selec-
tion of study population differs between studies, e.g.,
blood donors, subjects having been bitten by ticks, pa-
tients having suffered from LB, patients having suffered
from LNB, etc. Secondly, the choice of questionnaire
also varies. We are not aware of other studies using the
SHC inventory in blood donors or in relation to LB.
Nevertheless, in the following, a tentative comparison is
attempted.
In a study of 1156 male military recruits in Germany,
Treib and co-workers found that Borrelia IgG positive
subjects reported significantly more fatigue, general
malaise and limb pain, compared to seronegatives [33].
This is in contrast to our findings, where musculo-
skeletal pain in different locations as well as “tiredness”,
“reduced general function” and “reduced physical fitness”
was reported as often by seronegatives as by seropositives
for IgG.
Studies by Shadic and co-workers from 1994 and 1999
found that persons with a history of LB had more mus-
culoskeletal impairment and a higher prevalence of ver-
bal memory impairment when compared with those
without a history of LB [8, 9]. As these reports are based
on a different study population as well as a different
questionnaire, they are not directly comparable with our
present study. However, our results do not corroborate
these findings, as musculoskeletal pain and reduced gen-
eral function were not found associated with seropositiv-
ity or number of tick bites.
In agreement with our results, Seltzer and co-workers
[10] reported that persons having suffered from LB gen-
erally did not report more symptoms than controls, in-
cluding memory problems, numbness, fatigue, swollen
joints, headaches, neck pain, or problems with sleeping
and exercise. Also, supporting our findings, in two re-
cent Slovenian studies of patients treated for erythema
migrans, the researchers did not find any association be-
tween cases and controls in non-specific symptoms
6 months after treatment [15, 16]. In long-term follow-
up of patients with culture-confirmed LB, Wormser and
co-workers did not find evidence of severe fatigue or
fibromyalgia attributable to LB [11, 12], and summary
scores of physical and mental health were similar to
those of the general population [14].
As part of the Swedish “STING-study”, Fryland and
co-workers [17] compared symptoms in patients bitten
by ticks infected with Borrelia burgdorferi sensu lato
with patients bitten with non-infected ticks. They found
a higher frequency of patients reporting any symptom in
the former group, but no differences between the groups
when comparing the frequency of each of several symp-
toms. In the present study, we found that the count of
subjective health complaints had no relation with any of
the risk factors (Table 3).
In a prospective investigation of patients treated for
LNB in Norway, Eikeland and co-workers found that
LNB-treated patients scored lower on all the SF-36 sub-
scores except on bodily pain, and they reported fatigue,
memory problems and concentration difficulties more
often than matched controls [6]. Notable was that in
contrast to the results from Shadic et al., pain was not
more common among LNB-treated patients than among
controls, neither assessed by direct question nor by
SF-36. These data are not comparable to our study,
as very few, if any, of our study subjects have suffered
from LNB [18].
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According to alternative views on LB, there are many
undiagnosed patients with nonspecific chronic symp-
toms attributable to the disease [3]. Among the listed
symptoms, some are included in the SHC inventory. The
prevalence of these was not significantly higher for any
of the risk factors tick bites, IgG or IgM in our study.
However, a number of symptoms are not explicitly in-
cluded in the SHC inventory. If these symptoms were of
any significance in our study population, it should be
reflected in the score on “reduced general function”
in subjects with the risk factors. This was, however,
not the case.
The clear correlation between the number of tick bites
and physical fitness is not surprising. Persons more ex-
posed to ticks are presumably more involved in outdoors
activities such as hiking and hunting, and are in a gener-
ally good physical condition.
The negative association of “pseudoneurological” com-
plaints and Borrelia IgG antibodies, but not number of
tick bites or IgM, is difficult to explain. Also here, a
spurious relationship connected to confounding lifestyle
factors can be suspected.
The strength of this study is the relatively large repre-
sentation of healthy subjects from Sogn and Fjordane
county, the good response rate, and the frequent occur-
rence of tick bites and seropositivity to B. burgdorferi
s.l., as well as the scope of the questionnaire, covering a
broad range of health complaints. Thus, major chronic
health effects of tick bites and seropositivity to B. burg-
dorferi s.l. should be detected.
On the other hand, blood donors are not completely
representative of the general population. They are
healthy, and children and persons over 70 years are not
represented. There was, however, a fair distribution re-
garding gender and age groups. According to Norwegian
blood bank regulations, persons that have been bitten by
ticks should not donate blood within four weeks of the
bite, and persons with suspected or verified LB should
not donate until six months after adequate treatment
has been given [34]. Donors with recent tick bites and/
or LB may therefore be underrepresented. Not all tick
bites are recognized by the bitten person, and thus will
not be reported in a questionnaire survey like this (i.e.,
information bias). This is supported by the seropre-
valence rate for immunoblot verified IgG antibodies to
B. burgdorferi s.l. of 2.4 % in subjects not reporting any
tick bite [19].
It is to be expected that persons with significant chronic
health problems do not volunteer as blood donors, or will
be excluded. Persons of this category are therefore prob-
ably underrepresented in this material. However, given the
commonness of these “soft” symptoms also in blood
donors (Table 2), one would expect that mild degrees of
such complaints should be represented.
Conclusions
This study of blood donors in western Norway assessed
the association between three risk factors – the number
of tick bites ever experienced and the presence of Borrelia
IgG and IgM antibodies – with the questionnaire-based
outcomes general function, physical fitness and 29 differ-
ent subjective health complaints.
A limitation of this study is that very few of the study
subjects reported ever having had symptoms indicative
of systemic LB.
There was no association between general function
and the risk factors. However, we found a clear correl-
ation between the number of tick bites ever experienced
and good physical fitness. This most probably represents
a spurious relationship as both risk factor and outcome
are related to a healthy life style.
We did not find any association between more subject-
ive health complaints and tick bites or Borrelia antibodies.
Seeing the «pseudoneurological» group of complaints
together, there were fewer complaints in subjects with
Borrelia IgG antibodies, also probably a non-causal
relationship.
The results do not support any association between
tick bites or Borrelia antibodies and subjective health
complaints in blood donors in an endemic area for Lyme
borreliosis.
Additional file
Additional file 1: Individual subjective health complaints relative to
tick bites and Borrelia antibodies.
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